Although experimental studies strongly support the roles of insulin resistance, FXR-FGF19 signaling axis, and gut microbiome in GSD pathogenesis, direct measurements of their specific effects in humans remain limited, with most evidence derived from indirect measurements or observational studies rather than prospective interventional research. Here, FGF19 is linked to disorder of glycogen metabolism.